This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

GeneLink Announces HelixLife Private Label Distribution Agreement

ORLANDO, Fla., Sept. 24 /PRNewswire/ -- GeneLink BioSciences, Inc. (OTC Bulletin Board: GNLK, www.genelinkbio.com) today announced the launch of HelixLife, ( www.helixlife.com), a private label distribution partnership serving the healthcare and wellness industries.

Gary Beeman, GeneLink CEO, stated, "HelixLife gives GeneLink reach into new areas of the rapidly expanding personalized wellness markets that previously have not been available to us.  The HelixLife team is very experienced and will expand the visibility and healthcare market penetration of our 'Powered by GeneLink' technologies and our unique genetically-guided nutritional and skin care products."  

Brad Rex, HelixLife CEO added, "We are excited to showcase GeneLink's 16 years of incredible DNA research and product development with the HelixLife product line of anti-aging nutritional supplements and skin serums, youth supplements and anti-acne products.  We look forward to working together to optimize our customer's health, appearance and well being."

The HelixLife product line includes:  

HelixLife brilliant™ custom DNA nutritional adult supplements and anti-aging skin serum formulated and manufactured to each customer's specific genetic profile,

HelixLife assess™ DNA nutritional and skin assessment test,

HelixLife bright™ full-spectrum adult foundational supplements,

HelixLife grow™ nutritional supplements custom-designed for youth ages 11-17,

HelixLife glow™ natural and organic anti-aging skin serum,

HelixLife clear™ non-chemical based anti-acne skin serum, and

HelixLife active™ chocolate-based energy chews, a healthy alternative to energy drinks

HelixLife products are manufactured in the USA from the highest quality, freshest ingredients, and are shipped directly from production to customer, not warehouse-stored.  For more information, go to www.helixlife.com.

About GeneLink BioSciences, Inc.  

GeneLink is a genomics, biotechnology, and wellness company engaged in genetic test development, product development, and manufacturing of personalized wellness products.  GeneLink's patented and proprietary technologies include genetic assessments focused on the delivery of personally customized and manufactured nutritional supplements and skin care products for health, beauty and wellness applications. For additional information, please visit www.genelinkbio.com .

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.



SOURCE GeneLink BioSciences, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs